Healthcare analytics company Decision Resources Group is growing its healthcare data trove in a big way, adding claims and electronic health record data for its new Real World Evidence repository, or RWE.
DRG touts the fact that RWE, meant to offering its clients better patient insights and help them do longitudinal analytics, covers 90 percent of the U.S. healthcare system
The company did not release the cost of the data acquired.
Brigham Hyde, senior vice president of analytics and chief data officer at DRG, said the amount of data it now has available for licensing to its clients – all of it de-identified – far surpasses that offered by Truven and other data companies.
“We have four times as many patients as Truven has and six times as many claims, and we have EHR detail,” Hyde said.
IBM announced February 18 it would purchase analytics company Truven, adding a massive repository of data to its Watson Health Cloud.
[Also: IBM Watson buying Truven Health Analytics for $2.6 billion]
DRG is expanding its expertise to offer its clients more complete and dynamic analyses in the following areas: health economics and outcomes research, epidemiology validation, patient-level forecasting and market sizing, patient-level compliance and real-time network influence.
The RWE data asset comes from multiple data providers in the U.S. and includes patient, healthcare professional and payer-level analysis.
“As healthcare continues its shift from volume to value, DRG’s RWE repository enables academic grade analysis of the cost centers of healthcare in the U.S., as well as the behaviors and outcomes of treatment and coverage decisions,” Hyde said.
The repository covers 240 million unique U.S. patients with more than five years of historical data, and has 3.2 billion medical and pharmacy claims, enabling closer analysis of cost and outcomes data, according to DRG.
Hyde said DRG would leverage its nearly 400 analysts worldwide to provide customers with disease specific insights. For example, the repository has strong coverage of Type 2 diabetes, along with payment details, lab values and clinical progress of patients.
DRG also is using the RWE repository to make available custom and interactive analytic dashboards and analytics to enable clients to answer important business questions quickly.
In a separate announcement today, DRG said the board of directors appointed Jonathan Sandler CEO. Sandler also serves as DRG chairman of the board.
